A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors Academic Article uri icon

Overview

publication date

  • December 21, 1999

Research

keywords

  • Research article

Identity

Digital Object Identifier (DOI)

  • 10.1023/A:1006391619009

PubMed ID

  • 10619499

Additional Document Info

start page

  • 155

end page

  • 162

volume

  • 44